3Sneige N, Ordonez N G, Veanattukalathil S, et al. Fine-needle aspiration cytology in pancreatic endocrine tumors [ J ]. Diagn Cytopathol, 1987,3( 1 ) :35 -40.
4Ishida M, Seki K, Tatsuzawa A, et al. Primary hepatic neuroendocrine carcinoma coexisting with hepatocellular carcinoma in hepatiti C liver cirrhosis : report of a case [ J ]. Surg Today, 2003,33 ( 3 ) : 214 -218.
6Nishigami T, Yamada M, Nakasho K, et al. Carcinoid tumor of the gall bladder. Intern Med, 1996, 35: 953-956.
7李媛.肝类癌1例[J].中国实用内科杂志,1998,18:693-693.
8Takayasu K, Muramatsu Y, Sakamoto M, et al. Findings in primary hepatic carcinoid tumor: US, CT, MRI, and angiography. J Comput Assist Tomogr, 1992,16: 99-102.
9Tsuchimochi S, Nakajo M,Inoue H,et al. Primary hepatic neuroendocrine carcinoma with multiple metastases: a case report. Radiat Med,1995,13: 183-185.
10Kehagias D,Moulopoulos L,Smirniotis V,et al. Imaging findings in primary carcinoid tumour of the liver with gastrin production. Br J Radiol,1999, 72: 207-209.
3Alekseev D, Goralczyk A, l.orf T, et al. Ten years survival with excellent outcome after living donor liver transplantation from 70 years old donor for primary hepatic neuroendocrine carcinoma: Case report. Int J SurgCaseRep, 2012,3:34-36.
4Schwartz G, Colanta A, Gaetz H, et aL Primary carcinoid tumors of the liver. World J Surg Oncol, 2008,6:91.
5Lin CW, l.ai CH, Hsu ('C, et al. Primary hepatic carcinoid tumor: a case report and review of the literature. Cases J, 2009,2 : 90.
6Bosman FT, Carneiro F, Hruban RH, et al. WHO classi- fication of tumors of the digestive system. 4th ed. Lyon: ]ARC Press,2010=46 58.
7Mima K, Beppu T, Murata A, et al. Primary neuroendocrine tumor in the liver treated by hepatectomy report of a case. Surg Today, 2011,41;1655-1660.
8de Liguori Carino N, Manzia TM, Tariciotti L, et al. I.iver transplantation in primary hepatic carcinoid tumor: case report and literature review. Transplant Proc, 2009,41 : 1386-1389.
9Rinke A, Miiller HH, Sehade-grittinger C, et al. Placebo- controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group. J Clin Oncol, 200.9, 27:4656-4663.
10Huang YQ, Xu F, Yang JM, et al. Primary hepalic neuroendn- trine carcinoma: clinical analysis of I 1 cases [ J ]. Hcpatobiliary Pancreat Dis 1nt,2010,9( 1 ) :44 -48.
